UBS Group’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $314K | Sell |
249,103
-333,775
| -57% | -$421K | ﹤0.01% | 5192 |
|
|
2025
Q1 | $532K | Buy |
582,878
+186,511
| +47% | +$170K | ﹤0.01% | 4641 |
|
|
2024
Q4 | $630K | Buy |
396,367
+239,049
| +152% | +$380K | ﹤0.01% | 4549 |
|
|
2024
Q3 | $308K | Buy |
157,318
+50,782
| +48% | +$99.5K | ﹤0.01% | 4392 |
|
|
2024
Q2 | $175K | Sell |
106,536
-301,739
| -74% | -$495K | ﹤0.01% | 4642 |
|
|
2024
Q1 | $2.1M | Buy |
408,275
+81,746
| +25% | +$420K | ﹤0.01% | 2943 |
|
|
2023
Q4 | $1.87M | Buy |
326,529
+175,023
| +116% | +$1M | ﹤0.01% | 2914 |
|
|
2023
Q3 | $724K | Buy |
151,506
+35,628
| +31% | +$170K | ﹤0.01% | 3349 |
|
|
2023
Q2 | $492K | Sell |
115,878
-23,877
| -17% | -$101K | ﹤0.01% | 3836 |
|
|
2023
Q1 | $742K | Sell |
139,755
-54,896
| -28% | -$291K | ﹤0.01% | 3411 |
|
|
2022
Q4 | $1.22M | Buy |
194,651
+145,749
| +298% | +$915K | ﹤0.01% | 2978 |
|
|
2022
Q3 | $515K | Buy |
48,902
+35,055
| +253% | +$369K | ﹤0.01% | 3343 |
|
|
2022
Q2 | $75K | Sell |
13,847
-1,794
| -11% | -$9.72K | ﹤0.01% | 4629 |
|
|
2022
Q1 | $143K | Sell |
15,641
-2,293
| -13% | -$21K | ﹤0.01% | 4644 |
|
|
2021
Q4 | $271K | Buy |
17,934
+8,976
| +100% | +$136K | ﹤0.01% | 4414 |
|
|
2021
Q3 | $214K | Buy |
+8,958
| New | +$214K | ﹤0.01% | 4222 |
|